01
Cell-level structure
Our optics capture detailed, cell-by-cell structure — far more than a number on a chart, and information chemistry cannot see.
The Gap
Standard blood work is 50-year-old technology.
CBCs count cells. They don't see how cells are built, how they behave, or how they're changing. Clinicians work from averages and chemistry — slow, piecemeal, and blind to early signals.
0
years — CBC technology largely unchanged
0
global hematology market
0
of CBCs trigger follow-on tests
How it works
Light reads what chemistry misses.
A single optical reading, interpreted by software built to surface what standard panels miss. No reagents. No phlebotomist. No waiting on a central lab.
We design and test with equity in mind — so the platform performs reliably for everyone it serves.
[ Visualization ]
02
Deeper composition
The same reading surfaces compositional and functional signals — the kind of detail conventional chemistry can't reach.
03
Intelligent interpretation
Software turns each reading into clinically familiar results — and keeps getting better over time, without new hardware.
Pulse
First commercial device- Reagent-free optical core
- Fingerstick sample
- CBC + 5-part differential
- Point-of-care ready
Nexus
Second-generation · in development- Built on the same optical core
- Broadens beyond the complete blood count
- More to share soon
Where we are
Phase 0. First blood draws. First partner.
-
✓ Active Now — Month 6
Prototype. 100+ sample target. Q-Sub filing with FDA. Alpha partner: Wake Forest Baptist Hospital.
-
→ Upcoming Month 6–12
RUO label → pharma & academic placements, peer publications.
-
→ Month 12–18
510(k) submission, validation sites.
-
→ Month 18–24
FDA clearance, first revenue, 10 installs.
-
→ Month 24–36
Expanded claims, 50+ installs, $10–20M ARR.
Regulatory pathway modeled on Sysmex XW-100 dual 510(k) + CLIA Waiver precedent (K172604 / CW170012).
The Team
Built by people who've done this before.
Advisory Board
Mark A. Giffen, M.D.
Pathologist / Vice Chair, Wake Forest Baptist
Clint Ballinger, PhD
Entrepreneur / Inventor; Optics Expert
Eric Ledet, PhD
Medical Device Startup Founder / Bio-Medical Engineer
Anthony Ronga
Former Biotech Entrepreneur
Adam Sah
Serial Entrepreneur / Startup InvestorPartner with us
Run a pilot. Shape the science.
Hospitals & Health Systems
Pilot the device in ED or ICU settings. Real samples, shared data, early access to expanded capabilities.
Research Labs
Access rich optical cell data for publications, platform exploration, and pre-clinical research.
Strategic Investors
We're raising. Talk to us about where diagnostics is going and why optics is the answer.
Next step
Let's talk.
We'll connect you with the right person for demos, pilots, and investment conversations.
VidaLens is in prototype stage. This site is not medical advice.